204 related articles for article (PubMed ID: 38533301)
1. Impact and prevalence of comorbidities and complications on the severity of COVID-19 in association with age, gender, obesity, and pre-existing smoking: A meta-analysis.
Djorwé S; Bousfiha A; Nzoyikorera N; Nyandwi J; Kawthar B; Malki A
Biomedicine (Taipei); 2024; 14(1):20-38. PubMed ID: 38533301
[TBL] [Abstract][Full Text] [Related]
2. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
Li X; Zhong X; Wang Y; Zeng X; Luo T; Liu Q
PLoS One; 2021; 16(5):e0250602. PubMed ID: 33939733
[TBL] [Abstract][Full Text] [Related]
3. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.
Chenchula S; Vidyasagar K; Pathan S; Sharma S; Chavan MR; Bhagavathula AS; Padmavathi R; Manjula M; Chhabra M; Gupta R; Amerneni KC; Ghanta MK; Mudda S
Sci Rep; 2023 Apr; 13(1):6415. PubMed ID: 37076543
[TBL] [Abstract][Full Text] [Related]
4. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis.
Zhou Y; Yang Q; Chi J; Dong B; Lv W; Shen L; Wang Y
Int J Infect Dis; 2020 Oct; 99():47-56. PubMed ID: 32721533
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.
Dessie ZG; Zewotir T
BMC Infect Dis; 2021 Aug; 21(1):855. PubMed ID: 34418980
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: A systemic review and meta-analysis.
Giri M; Puri A; Wang T; Guo S
Sci Prog; 2021; 104(1):368504211000906. PubMed ID: 33752530
[TBL] [Abstract][Full Text] [Related]
9. Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
Rahman MM; Bhattacharjee B; Farhana Z; Hamiduzzaman M; Chowdhury MAB; Hossain MS; Siddiqee MH; Islam MZ; Raheem E; Uddin MJ
J Prev Med Hyg; 2021 Jun; 62(2):E329-E371. PubMed ID: 34604574
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and predictors associated with the severity of COVID-19 in China: a systematic review, meta-analysis, and meta-regression.
Zhang T; Huang WS; Guan W; Hong Z; Gao J; Gao G; Wu G; Qin YY
J Thorac Dis; 2020 Dec; 12(12):7429-7441. PubMed ID: 33447431
[TBL] [Abstract][Full Text] [Related]
11. Age-Adjusted Risk Factors Associated with Mortality and Mechanical Ventilation Utilization Amongst COVID-19 Hospitalizations-a Systematic Review and Meta-Analysis.
Patel U; Malik P; Usman MS; Mehta D; Sharma A; Malik FA; Khan N; Siddiqi TJ; Ahmed J; Patel A; Sacks H
SN Compr Clin Med; 2020; 2(10):1740-1749. PubMed ID: 32904541
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis.
Chen Z; Peng Y; Wu X; Pang B; Yang F; Zheng W; Liu C; Zhang J
Front Public Health; 2022; 10():923485. PubMed ID: 36052001
[TBL] [Abstract][Full Text] [Related]
13. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
14. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis.
Khan MMA; Khan MN; Mustagir MG; Rana J; Islam MS; Kabir MI
J Glob Health; 2020 Dec; 10(2):020503. PubMed ID: 33110586
[TBL] [Abstract][Full Text] [Related]
15. Associations of pre-existing cardiovascular morbidity with severity and the fatality rate in COVID-19 patients: a systematic review and meta-analysis.
Alzoughool F; Abumweis S; Alanagreh L; Atoum M
Osong Public Health Res Perspect; 2022 Feb; 13(1):37-50. PubMed ID: 35255677
[TBL] [Abstract][Full Text] [Related]
16. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.
Harwood R; Yan H; Talawila Da Camara N; Smith C; Ward J; Tudur-Smith C; Linney M; Clark M; Whittaker E; Saatci D; Davis PJ; Luyt K; Draper ES; Kenny SE; Fraser LK; Viner RM
EClinicalMedicine; 2022 Feb; 44():101287. PubMed ID: 35169689
[TBL] [Abstract][Full Text] [Related]
17. The likelihood of severe COVID-19 outcomes among PLHIV with various comorbidities: a comparative frequentist and Bayesian meta-analysis approach.
Wang H; Jonas KJ
J Int AIDS Soc; 2021 Nov; 24(11):e25841. PubMed ID: 34797952
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.
Alqahtani JS; Oyelade T; Aldhahir AM; Alghamdi SM; Almehmadi M; Alqahtani AS; Quaderi S; Mandal S; Hurst JR
PLoS One; 2020; 15(5):e0233147. PubMed ID: 32392262
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus (COVID-19): A Systematic Review and Meta-analysis to Evaluate the Significance of Demographics and Comorbidities.
Bhattacharyya A; Seth A; Srivastava N; Imeokparia M; Rai S
Res Sq; 2021 Jan; ():. PubMed ID: 33469575
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy.
Türk SM; Öztürk Z; Karataş D; Erkorkmaz Ü; Gönüllü E
Turk J Med Sci; 2022 Apr; 52(2):522-523. PubMed ID: 36161620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
